Tiziana Life Sciences PLC Skyrocketed

Tiziana Life Sciences PLC (TLSA:NASDAQ) jumped higher at $4.73, representing a gain of 49.2%. The stock got featured on our News Catalysts scanner on Wed 20 Jan 21 at 07:32 AM in the 'MISCELLANEOUS' category. From Tue 05 Jan 21, the stock recorded 55.56% Up Days and 60.00% Green Days

The stock spiked on Wed 13 Jan 21 at $4.3 with a volume of 6M+.

About Tiziana Life Sciences PLC (TLSA:NASDAQ)

Tiziana Life Sciences PLC is involved in the business of developing novel therapeutics for cancer with a focus on late-stage growth and complementary diagnostic tools, with the capability of predicting disease aggressiveness and prognosis in breast cancer patients. The group also has interests, beyond pure oncology, in the discovery and development of monoclonal antibody-based biologics used to benefit patients with inflammatory and auto-immune disorders. The company has a single reporting segment, The Research, and Development of Biotechnological and Pharmaceutical Products. Its lead compound, milciclib (TZLS-201), is a molecule which blocks the action of specific enzymes involved in cell division as well as a number of other protein kinases.